Maverick Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Buy
+2,562
New +$1.02M 0.01% 177
2023
Q4
– Sell
-1,882
Closed -$506K – 356
2023
Q3
$506K Buy
+1,882
New +$470K 0.01% 178
2021
Q3
– Sell
-1,670
Closed -$407K – 636
2021
Q2
$407K Buy
1,670
+1,561
+1,432% +$384K ﹤0.01% 407
2021
Q1
$27K Buy
+109
New +$26K ﹤0.01% 660
2019
Q4
– Sell
-4,862
Closed -$941K – 345
2019
Q3
$941K Buy
+4,862
New +$933K 0.01% 289
2017
Q3
– Sell
-10,200
Closed -$1.76M – 180
2017
Q2
$1.76M Buy
10,200
+6,420
+170% +$1.04M 0.02% 150
2017
Q1
$620K Sell
3,780
-790
-17% -$131K 0.01% 126
2016
Q4
$668K Buy
4,570
+940
+26% +$141K 0.01% 111
2016
Q3
$606K Sell
3,630
-310
-8% -$52.4K 0.01% 120
2016
Q2
$599K Buy
3,940
+480
+14% +$74.6K 0.01% 117
2016
Q1
$519K Buy
3,460
+1,780
+106% +$264K 0.01% 112
2015
Q4
$273K Hold
1,680
– – ﹤0.01% 94
2015
Q3
$232K Hold
1,680
– – ﹤0.01% 108
2015
Q2
$258K Buy
1,680
+110
+7% +$17.6K ﹤0.01% 90
2015
Q1
$251K Buy
+1,570
New +$247K ﹤0.01% 104

Other funds holding AMGN

Maverick Capital's AMGN Position: Q3 2026 in Review

Maverick Capital opened a new position in Amgen (AMGN) in Q3 2026: 2,562 shares worth $1.08M. The stake represents 0.01% of the portfolio and ranks #177 among its holdings. This is a return to the name: Maverick Capital previously reported a position in AMGN as recently as Q3 2023.

Maverick Capital first reported a position in AMGN in Q1 2015 and has held it in 15 quarters since. The position peaked at $1.76M in Q2 2017. 3,272 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Maverick Capital held 2,562 shares of Amgen worth $1.08M as of Q3 2026.
  • Amgen was a new Maverick Capital position in Q3 2026.
  • Amgen made up 0.01% of Maverick Capital's portfolio in Q3 2026, its #177 holding.
  • Maverick Capital first reported a position in Amgen in Q1 2015 and has held it in 15 quarters since.
  • Maverick Capital's Amgen position peaked at $1.76M in Q2 2017.
  • 3,272 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.